BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 17565257)

  • 41. The role of surgery in the management of gastrointestinal stromal tumors (GISTs) in the era of imatinib mesylate effectiveness.
    Kosmadakis N; Visvardis EE; Kartsaklis P; Tsimara M; Chatziantoniou A; Panopoulos I; Erato P; Capsambelis P
    Surg Oncol; 2005 Aug; 14(2):75-84. PubMed ID: 15993051
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Surgical treatment of an advanced GIST the age of imatinib].
    Fernández JA; Parrilla P
    Cir Esp; 2009 Jul; 86(1):3-12. PubMed ID: 19539273
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adjuvant imatinib treatment improves recurrence-free survival in patients with high-risk gastrointestinal stromal tumours (GIST).
    Nilsson B; Sjölund K; Kindblom LG; Meis-Kindblom JM; Bümming P; Nilsson O; Andersson J; Ahlman H
    Br J Cancer; 2007 Jun; 96(11):1656-8. PubMed ID: 17533389
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Downstaging of a gastric GIST by neoadjuvant imatinib and endoscopic assisted laparoscopic resection.
    Cavaliere D; Vagliasindi A; Mura G; Framarini M; Giorgetti G; Solfrini G; Tauceri F; Padovani F; Milandri C; Dubini A; Ridolfi L; Ricci E; Verdecchia GM
    Eur J Surg Oncol; 2007 Oct; 33(8):1044-6. PubMed ID: 17467951
    [No Abstract]   [Full Text] [Related]  

  • 45. [A case report of two-term surgery for focal progression of a huge liver metastasis and peritoneal dissemination from gastrointestinal stromal tumor during imatinib mesylate treatment].
    Toyokawa T; Teraoka H; Kitayama K; Nomura S; Kanehara I; Nishino H
    Gan To Kagaku Ryoho; 2014 Mar; 41(3):373-7. PubMed ID: 24743287
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Treatment of gastrointestinal stromal tumor (GIST)--review of the literature and a case report].
    Geraci G; Li Volsi F; Pisello F; Sciumè C; Cajozzo M; Cavaleri C; Modica G
    Ann Ital Chir; 2005; 76(4):377-80; discussion 381. PubMed ID: 16550875
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [A gastric stromal tumor (GIST) with a prolonged partial response to a reduced dose of imatinib mesilate].
    Nakatani K; Tanabe S; Nishimura K; Shimoda T; Azuma M; Katada C; Sasaki T; Higuchi K; Koizumi W; Saigenji K
    Gan To Kagaku Ryoho; 2006 Jul; 33(7):997-1000. PubMed ID: 16835496
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Gastrointestinal stromal tumours: a broad spectrum of clinical presentations].
    Pacelli F; Rosa F; Papa V; Tortorelli AP; Sanchez AM; Covino M; Sofo L; Doglietto GB
    Chir Ital; 2007; 59(6):771-9. PubMed ID: 18360981
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Treatment of metastatic gastrointestinal stromal tumors with Imatinib: report of four cases].
    Garrido S M; Moneada M M; Tapia N G; Méndez O G; Galindo A H; Huete G A; Ibáñez A L; González S; Alvarez Z M
    Rev Med Chil; 2007 Oct; 135(10):1327-32. PubMed ID: 18180842
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gastrointestinal stromal tumour treated with neoadjuvant imatinib.
    Loughrey MB; Mitchell C; Mann GB; Michael M; Waring PM
    J Clin Pathol; 2005 Jul; 58(7):779-81. PubMed ID: 15976351
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [How should patients with completely resected gastrointestinal stromal tumours (GIST) be followed up?].
    Stelzner S; Antoni C; Haroske G; Jacobasch L; Erk JU; Ludwig K
    Zentralbl Chir; 2005 Dec; 130(6):554-61. PubMed ID: 16382404
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gastric GIST: a single institutional retrospective experience with surgical treatment for primary disease.
    An JY; Choi MG; Noh JH; Sohn TS; Kang WK; Park CK; Kim S
    Eur J Surg Oncol; 2007 Oct; 33(8):1030-5. PubMed ID: 17428635
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Pathological complete response in a large gastric GIST that became resectable after neoadjuvant chemotherapy with imatinib mesylate].
    Otsubo D; Sawa H; Fukuoka E; Murata K; Mii Y; Oka S; Iwatani Y; Kuroda D
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):2402-4. PubMed ID: 25731537
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [A patient with metastatic gastrointestinal stromal tumor who responded to STI571].
    Terashima M; Abe K; Takeda Y; Saito K; Uesugi N; Kato K; Sato K; Maekawa T
    Gan To Kagaku Ryoho; 2002 Apr; 29(4):607-10. PubMed ID: 11977548
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [A case of gastric gastrointestinal stromal tumor resected after chemotherapy with imatinib].
    Kikuchi D; Ishii Y; Saitou M; Yamada M; Takenoshita S
    Gan To Kagaku Ryoho; 2011 Jul; 38(7):1201-4. PubMed ID: 21772112
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gastrointestinal stromal tumour in a young adult.
    Samuel DO; Philip I; Omotara SM
    J Coll Physicians Surg Pak; 2010 Sep; 20(9):618-9. PubMed ID: 20810057
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Two cases of surgical resection of rectal gastrointestinal stromal tumor after neoadjuvant therapy with imatinib mesylate].
    Nakashima S; Fujita Y; Matsuo H; Ariyoshi Y; Fukuda K; Fujiyama J; Masuyama M
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):1932-4. PubMed ID: 23267934
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Long-term survival in a case of recurrent gastrointestinal stromal tumor treated with intermittent or low-dose imatinib].
    Kurata Y; Takaishi S; Sakuma Y; Iwasaki K; Nimura Y; Tohma T; Kagaya A; Yamamoto Y; Matsubara H
    Gan To Kagaku Ryoho; 2014 Mar; 41(3):379-82. PubMed ID: 24743288
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Different factors are responsible for predicting relapses after primary tumors resection and for imatinib treatment outcomes in gastrointestinal stromal tumors.
    Rutkowski P; Debiec-Rychter M; Nowecki ZI; Wozniak A; Michej W; Limon J; Siedlecki JA; Jerzak Vel Dobosz A; Grzesiakowska U; Nasierowska-Guttmejer A; Sygut J; Nyckowski P; Krawczyk M; Ruka W
    Med Sci Monit; 2007 Nov; 13(11):CR515-522. PubMed ID: 17968300
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Two cases of recurrent GIST successfully treated with imatinib mesylate at 100mg/day].
    Hanada N; Kawata K; Okamura S; Tomiyama N; Hori K
    Gan To Kagaku Ryoho; 2013 Jun; 40(6):803-5. PubMed ID: 23863663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.